Shin Nippon Biomedical Laboratories, Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

Date: October 15, 2014
Pages: 50
Price:
US$ 499.00
Shin Nippon Biomedical Laboratories, Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default), Hard Copy Mail Delivery (+US$ 190.00)
ID: S21F919669FBEN
Leaflet:

Download PDF Leaflet

Shin Nippon Biomedical Laboratories, Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Shin Nippon Biomedical Laboratories, Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between Shin Nippon Biomedical Laboratories, Ltd. and its competitors. This provides our Clients with a clear understanding of Shin Nippon Biomedical Laboratories, Ltd. position in the Pharmaceuticals and Biotechnology Industry.

  • The report contains detailed information about Shin Nippon Biomedical Laboratories, Ltd. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
  • Another part of the report is a SWOT-analysis carried out for Shin Nippon Biomedical Laboratories, Ltd.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
  • The Shin Nippon Biomedical Laboratories, Ltd. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
  • In the part that describes Shin Nippon Biomedical Laboratories, Ltd. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
  • Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Shin Nippon Biomedical Laboratories, Ltd. business.

About Shin Nippon Biomedical Laboratories, Ltd.

Shin Nippon Biomedical Laboratories, Ltd. offers a range of drug development services to pharmaceutical companies worldwide. It offers services in the areas of safety research, clinical pharmacology, and clinical trials. The company researches and extrapolates the safety of new drugs from various standpoints, primarily in the areas of toxicology, pharmacology, pathology, biochemistry, microbiology, genetic engineering, and drug metabolism. It also conducts Phase I clinical trials in collaboration with CPC Clinic, an affiliated medical institution, as well as provides support services for clinical trials. In addition, the company offers Phase I/IIa clinical research studies, as well as provides related statistical, analytical, and consulting services for various aspects of new drug development. Further, Shin Nippon supports the commercialization of promising research from academic and bioventure sources; offers high-speed nanoscale proteomic analysis; and provides proteomics consultation services for large-scale analyses of protein expression patterns and protein interactions. It has collaborations or partnerships with University of Maryland, Koryokai CPC Clinic, and St.Mary's Hospital. The company was founded in 1957 and is headquartered in Tokyo, Japan.


RESEARCH METHODOLOGY

DISCLAIMER

1. SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. COMPANY PROFILE

1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History

2. SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. BUSINESS OVERVIEW

2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units

3. SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. SWOT ANALYSIS

3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats

4. SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. FINANCIAL ANALYSIS

4.1. Financial Statements
  4.1.1. Income Statement
  4.1.2. Balance Sheet
  4.1.3. Cash Flow
4.2. Financial Ratios
  4.2.1. Profitability
  4.2.2. Margin Analysis
  4.2.3. Asset Turnover
  4.2.4. Credit Ratios
  4.2.5. Long-Term Solvency
  4.2.6. Growth Over Prior Year
  4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot

5. SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. COMPETITORS AND INDUSTRY ANALYSIS

5.1. Shin Nippon Biomedical Laboratories, Ltd. Direct Competitors
5.2. Comparison of Shin Nippon Biomedical Laboratories, Ltd. and Direct Competitors Financial Ratios
5.3. Comparison of Shin Nippon Biomedical Laboratories, Ltd. and Direct Competitors Stock Charts
5.4. Shin Nippon Biomedical Laboratories, Ltd. Industry Analysis
  5.4.1. Pharmaceuticals and Biotechnology Industry Snapshot
  5.4.2. Shin Nippon Biomedical Laboratories, Ltd. Industry Position Analysis

6. SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. NEWS & EVENTS

6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events

7. SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. EXPERTS REVIEW1

7.1. Experts Opinion
7.2. Experts Estimates

8. SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. ENHANCED SWOT ANALYSIS2

9. SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. PESTEL ANALYSIS2

9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors

10. SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. PORTER FIVE FORCES ANALYSIS2

11. SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. VRIO ANALYSIS2


APPENDIX 1: RATIO DEFINITIONS


LIST OF TABLES

Shin Nippon Biomedical Laboratories, Ltd. Key Facts
Profitability
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Shin Nippon Biomedical Laboratories, Ltd. Key Executives
Key Executives Biographies1
Key Executives Compensations1
Shin Nippon Biomedical Laboratories, Ltd. Major Shareholders
Shin Nippon Biomedical Laboratories, Ltd. History
Shin Nippon Biomedical Laboratories, Ltd. Products
Revenues by Product
Revenues by Region
Shin Nippon Biomedical Laboratories, Ltd. Offices and Representations
Shin Nippon Biomedical Laboratories, Ltd. SWOT Analysis
Income Statement Including 4-years Trends
Income Statement Latest 4 Quarters Including Trends
Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Shin Nippon Biomedical Laboratories, Ltd. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Shin Nippon Biomedical Laboratories, Ltd. Capital Market Snapshot
Shin Nippon Biomedical Laboratories, Ltd. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Pharmaceuticals and Biotechnology Industry Statistics
Shin Nippon Biomedical Laboratories, Ltd. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Shin Nippon Biomedical Laboratories, Ltd. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Historical Surprises1
Revenue Estimates Trend1
Earnings Estimates Trend1
Revenue Revisions1
Enhanced SWOT Analysis2
Porter Five Forces Analysis2

LIST OF FIGURES

Shin Nippon Biomedical Laboratories, Ltd. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Shin Nippon Biomedical Laboratories, Ltd. 1-year Stock Charts
Shin Nippon Biomedical Laboratories, Ltd. 5-year Stock Charts
Shin Nippon Biomedical Laboratories, Ltd. vs. Main Indexes 1-year Stock Chart
Shin Nippon Biomedical Laboratories, Ltd. vs. Direct Competitors 1-year Stock Charts
Shin Nippon Biomedical Laboratories, Ltd. Article Density Chart

1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for public traded companies.

The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get up-to-date version for the same price. Please note that preparation of additional types of analyses requires extra time.

Enhanced SWOT Analysis

Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:

  • How to use the strengths to take advantage of the opportunities?
  • How to use the strengths to reduce likelihood and impact of the threats?
  • How to overcome the weaknesses that obstruct taking advantage of the opportunities?
  • How to overcome the weaknesses that can make the threats a reality?

Upon answering these questions a company can develop a Project Plan to improve its business performance.


PESTEL Analysis

PESTEL (also termed as STEP, PESTLE, STEEP, STEEPLE, STEEPLED, etc.) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.

Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.

Key Factors Examined by PESTEL Analysis:

  • Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
  • Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
  • Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
  • Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
  • Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
  • Legal – What laws and legislations will exert influence on the style the business is carried out?

Porter Five Forces Analysis

The extended Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions followed by sixth question added to the original concept:

  1. What composes a threat of substitute products and services?
  2. Is there a threat of new competitors entering the market?
  3. What is the intensity of competitive rivalry?
  4. How big is the bargaining power of buyers?
  5. How significant is the bargaining power of suppliers?
  6. Is there any complementary products, government decisions or public perception that can impact business?

VRIO Analysis

VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:

  • Tangible resources
    • Financial
    • Physical
    • Technological
    • Organizational
  • Intangible resources
    • Human
    • Innovation and Creativity
    • Reputation
  • Organizational capabilities

The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:

  • Valuable?
  • Rare?
  • Costly to Imitate?
  • Organized Properly?

Ask Your Question

Shin Nippon Biomedical Laboratories, Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: